KINDRED BIOSCIENCES
Summary
Kindred Biosciences is a clinical-stage biopharmaceutical company focused on saving and improving the lives of pets.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 312 M
Avg. Deal Size£ 312 M
Senior Management
Richard Chin
Founder and CEO
Katja Buhrer
Communications Director
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite